What is the Impact Factor of Brain Tumor Pathology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Brain Tumor Pathology is 2.20, ranking in quartile Q3 of Web of Science (SCIE).

Is Brain Tumor Pathology indexed in Web of Science or Scopus?

Yes, Brain Tumor Pathology is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.623 (Q2) and an H-index of 49.

Who publishes Brain Tumor Pathology and what is the Article Processing Charge (APC)?

Brain Tumor Pathology is published by Springer Singapore. The estimated Article Processing Charge (APC) is approximately $3,117 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Brain Tumor Pathology?

The official ISO-4 abbreviation of Brain Tumor Pathology is "BRAIN TUMOR PATHOL" with common acronym "btpa". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #9,435Hybrid

Brain Tumor Pathology

Acronym:btpa

•

Abbreviation (ISO):BRAIN TUMOR PATHOL

•

Identifier (ISSN):1433-7398(Print)/1861-387X(Online)

•

Publisher:Springer Singapore

Official Website Submission Portal Compare

Clarivate IF (2026)

2.2↓ -0.8

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Brain Tumor Pathology

WoS Q3

Annual Impact Factor Metric

Current (2026):2.2

Scopus SJR & RankScopus Q2

0.623

#9,435

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

49 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate11.1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

26articles/year

32.26% Gold OA•70.83% Original Research

Aims & Scope

Brain Tumor Pathology is the official journal of the Japan Society of Brain Tumor Pathology. This international journal documents the latest research and topical debate in all clinical and experimental fields relating to brain tumors, especially brain tumor pathology. The journal has been published since 1983 and has been recognized worldwide as a unique journal of high quality. The journal welcomes the submission of manuscripts from any country. Membership in the society is not a prerequisite for submission. The journal publishes original articles, case reports, rapid short communications, instructional lectures, review articles, letters to the editor, and topics.Review articles and Topics may be recommended at the annual meeting of the Japan Society of Brain Tumor Pathology. All contributions should be aimed at promoting international scientific collaboration.

Topics Covered (Recognized by AI)

Medicine98.5%Biology93.9%Pathology86.8%Internal medicine76.2%Genetics75%Radiology68%Surgery65.7%Psychology62.3%Psychiatry54.9%Cancer research50.3%Chemistry47%Biochemistry46%Immunology44.3%Neurosurgery42.2%Neuroscience40.7%Glioma35.1%Immunohistochemistry34.1%Gene33.1%Glioblastoma25.1%Endocrinology22.6%Anatomy20.5%

Primary Research Areas

Medicine Pathology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CLINICAL NEUROLOGY

Rank180/296

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank228/333

IndexSCIE

JCRSCIE2026

PATHOLOGY

Rank44/89

IndexSCIE

JCISCIE2026

CLINICAL NEUROLOGY

Rank195/296

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank196/333

IndexSCIE

JCISCIE2026

PATHOLOGY

Rank56/89

IndexSCIE

Category	Index	Rank	Quartile
CLINICAL NEUROLOGY	JCRSCIE	180/296	Q3
ONCOLOGY	JCRSCIE	228/333	Q3
PATHOLOGY	JCRSCIE	44/89	Q2
CLINICAL NEUROLOGY	JCISCIE	195/296	Q3
ONCOLOGY	JCISCIE	196/333	Q3
PATHOLOGY	JCISCIE	56/89	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.2

Articles / Year22

Total Citations0

2025

IF3

Articles / Year28

Total Citations17

2024

IF2.7

Articles / Year19

Total Citations62

2023

IF3.3

Articles / Year27

Total Citations175

2022

IF3.154

Articles / Year30

Total Citations301

Year	Impact Factor	Articles / Year	Total Citations
2026	2.2	22	0
2025	3	28	17
2024	2.7	19	62
2023	3.3	27	175
2022	3.154	30	301
2021	3.298	30	396
2020	2.348	32	627
2019	3.509	24	516
2018	2.535	32	660
2017	—	33	708
2016	—	39	833
2015	—	37	591

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,435Scopus Q2SCImago Profile

Scopus Coverage:1997-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q2

0.623

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

1.98

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,117 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations161

3-Year Documents74

Citable Documents63

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate23.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2

Cancer ResearchQ3

Neurology (clinical)Q3

OncologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 11.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Brain Tumor Pathology (acronym: btpa, abbr: BRAIN TUMOR PATHOL, ISSN: 1433-7398) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Singapore in Japan since 1997. The periodical holds a Journal Impact Factor (JIF) of 2.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.623 (Q2), an H-index of 49.

The journal enforces rigorous peer evaluation with a publication frequency of Semiannual, an annual output of approximately 26 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,117 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.